Melanóma: vizsgálatok itt: Franciaország
61 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleEvaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Életkor
- 18 év and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06971848 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors
- Where
- Grenoble, Lyon
- Életkor
- 18 év and over
- People
- 80
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT04068155 - No phaseTaking peopleResearch of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
- Where
- Toulouse
- Életkor
- 18 év and over
- People
- 450
- Run by
- Institut Claudius Regaud
See details and how to joinNCT06967961 - 3. fázisTaking peopleNeoadjuvant Darovasertib in Primary Uveal Melanoma
- Where
- Nice, Paris
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07015190 · EU 2025-522387-32-00 - 1/2. fázisNot yet taking people in FranciaországA First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Where
- Lille, Paris, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06413680 · EU 2025-523399-22-00 - No phaseTaking peopleGeneration of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
- Where
- Angers, Besançon, Blois, Bordeaux, Brest, Dijon, Grenoble, La Rochelle, Le Mans, Lyon, Nantes, Paris, Rennes, Rouen, Saint-Herblain, Valence
- Életkor
- 18 év and over
- People
- 700
- Run by
- Nantes University Hospital
See details and how to joinNCT05856565 - 2/3. fázisNot yet taking people in FranciaországA Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Where
- Lyon, Paris
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00 - 4. fázisTaking peopleETCABio - Evaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Életkor
- 18 év and over
- People
- 140
- Run by
- Centre Hospitalier Universitaire D'Angers
See details and how to join2024-519812-15-00 - No phaseTaking peopleIdentification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
- Where
- Clermont-Ferrand
- Életkor
- 18 év and over
- People
- 50
- Run by
- Centre Jean Perrin
See details and how to joinNCT06550674 - 1. fázisTaking peopleStudy to evaluate the safety of MAQ-001 as monotherapy and combination therapy in patients with advanced cancers
- Where
- Lyon, Rennes Cedex, Toulouse Cedex 9, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 30
- Run by
- MabQuest Therapeutics S.A.
See details and how to joinNCT06514651 · EU 2023-507774-41-00 - 3. fázisTaking peopleTebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- Where
- Bordeaux, Lyon, Marseille, Paris, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT05549297 · EU 2022-502732-39-00 - 3. fázisTaking peopleIMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Where
- Bobigny, Boulogne-Billancourt, Caen, Dijon, Lille, Marseille, Nantes, Paris, Pierre-Bénite, Rouen, Toulouse, Valence, Villejuif
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT06112314 - 2. fázisTaking peopleNeo-adjuvant Immunotherapy Master Trial for Localized Cancers
- Where
- Bordeaux, Lyon, Marseille, Paris, Pierre-Bénite, Villejuif
- Életkor
- 12 év and over
- People
- 200
- Run by
- UNICANCER
See details and how to joinNCT07262489 · EU 2025-522127-95-00 - 4. fázisTaking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- Lyon, Marseille, Villejuif
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - No phaseTaking peopleStudy of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
- Where
- Nice
- Életkor
- 18 év and over
- People
- 20
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT05307289 - No phaseTaking peoplePredictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021
- Where
- Strasbourg
- Életkor
- 18 év and over
- People
- 221
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07302607 - No phaseTaking peopleOvarian Reserve and Semen Parameters Evolution During Adjuvant Therapy in Melanoma
- Where
- Bordeaux, Marseille, Montpellier, Nantes, Nice, Nîmes, Paris, Toulouse, Villejuif
- Életkor
- 18 év to 45 év
- People
- 80
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT05429138 - No phaseTaking peopleFollow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
- Where
- Paris
- Életkor
- 18 év and over
- People
- 700
- Run by
- Institut Curie
See details and how to joinNCT04424719 - No phaseTaking peopleFrench Clinical Datbase of Melanoma Patients (RIC-Mel)
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 16 000
- Run by
- Nantes University Hospital
See details and how to joinNCT03315468 - No phaseNot yet taking people in FranciaországEfficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL
- Where
- Nice
- Életkor
- 18 év and over
- People
- 70
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07046728 - No phaseTaking peopleAPA (Adapted Physical Activity) for Patients With Advanced Melanoma
- Where
- Rouen
- Életkor
- 18 év and over
- People
- 50
- Run by
- University Hospital, Rouen
See details and how to joinNCT07031830 - No phaseTaking peopleImmune Profiles Evolution Under Immunotherapy for Melanoma
- Where
- Boulogne-Billancourt
- Életkor
- 18 év and over
- People
- 360
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04576429 - No phaseTaking peopleInterim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy
- Where
- Nice
- Életkor
- 18 év and over
- People
- 20
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT03888950 - No phaseTaking peopleReal-life Pharmacological Monitoring of Encorafenib-Binimetinib in the Treatment of Metastatic Melanoma
- Where
- Boulogne-Billancourt
- Életkor
- 18 év and over
- People
- 66
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06774989 - No phaseTaking peopleReview of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma
- Where
- Nice
- People
- 10
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT06861023